O ROURKE & COMPANY Inc Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)
O ROURKE & COMPANY Inc decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,625 shares of the financial services provider’s stock after selling 142 shares during the period. […]
More Stories
Versarien (LON:VRS) Shares Up 3.4% – Here’s Why
Versarien plc (LON:VRS – Get Free Report)’s share price shot up 3.4% on Monday . The company traded as high...
Ennis (NYSE:EBF) Releases Earnings Results, Meets Estimates
Ennis (NYSE:EBF – Get Free Report) announced its quarterly earnings results on Monday. The industrial products company reported $0.39 EPS...
Head-To-Head Survey: Shopify (NYSE:SHOP) versus Ceridian HCM (NYSE:CDAY)
Shopify (NYSE:SHOP – Get Free Report) and Ceridian HCM (NYSE:CDAY – Get Free Report) are both large-cap computer and technology...
Botswana Diamonds (LON:BOD) Stock Price Up 36.9% – Time to Buy?
Botswana Diamonds plc (LON:BOD – Get Free Report) shares were up 36.9% on Monday . The stock traded as high...
Thermo Fisher Scientific (NYSE:TMO) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank assumed coverage on shares of Thermo Fisher Scientific (NYSE:TMO – Get Free Report) in a...
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given “Market Outperform” Rating at JMP Securities
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “market outperform” rating restated by stock analysts at JMP Securities...